# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-25-328743
Filing Date
2025-12-22
Accepted
2025-12-22 16:11:40
Documents
103
Period of Report
2025-10-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | engn-20251031.htm iXBRL | 10-K | 3540815
2 | EX-10.32 | engn-ex10_32.htm | EX-10.32 | 150583
3 | EX-10.20(B) | engn-ex10_20b.htm | EX-10.20(B) | 12604
4 | EX-23.1 | engn-ex23_1.htm | EX-23.1 | 4335
5 | EX-31.1 | engn-ex31_1.htm | EX-31.1 | 17847
6 | EX-31.2 | engn-ex31_2.htm | EX-31.2 | 18052
7 | EX-32.1 | engn-ex32_1.htm | EX-32.1 | 10371
8 | EX-32.2 | engn-ex32_2.htm | EX-32.2 | 10019
9 | GRAPHIC | img209334158_0.jpg | GRAPHIC | 101817
10 | GRAPHIC | img209334158_1.jpg | GRAPHIC | 216773
11 | GRAPHIC | img209334158_2.jpg | GRAPHIC | 190064
12 | GRAPHIC | img209334158_3.jpg | GRAPHIC | 259639
13 | GRAPHIC | img209334158_4.jpg | GRAPHIC | 91995
14 | GRAPHIC | img209334158_5.jpg | GRAPHIC | 80936
15 | GRAPHIC | img209334158_6.jpg | GRAPHIC | 215853
16 | GRAPHIC | img209334158_7.jpg | GRAPHIC | 69123
17 | GRAPHIC | img209334158_8.jpg | GRAPHIC | 107905
18 | GRAPHIC | img209334158_9.jpg | GRAPHIC | 126604
19 | GRAPHIC | img209334158_10.jpg | GRAPHIC | 103008
| Complete submission text file | 0001193125-25-328743.txt |  | 17113397

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
20 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | engn-20251031.xsd | EX-101.SCH | 1546090
106 | EXTRACTED XBRL INSTANCE DOCUMENT | engn-20251031_htm.xml | XML | 2391309

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-41854 | Film No.: 251592563
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)